Effectiveness of Upadacitinib and Biologics for the Achievement of Minimal Disease Activity in Adults With Moderate-to-Severe Atopic Dermatitis (RAMpUp)
Clinical trial NCT07741838 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07741838
- Sponsor
- AbbVie
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-09-30
- Primary completion
- 2028-07-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.